“…The conformational space is vast, with the available X-crystal structures covering only a certain fraction, as recently elegantly documented for the Abl tyrosine kinase, for which molecular dynamics simulations and Markov state models identified a protein conformation apparently in a Lilly in-house structure of Abl with WHI-P15 but not in the Protein Data Bank (PDB) [57]. Even though here exploited for drug discovery, it is reasonable to expect that evolution has made use of such vast ensembles as well, adapting them in different ways [58, 59], including in thermostability [60, 61], diverse cellular environments [62], protein disorder and the switches between the ordered and the disordered state [63, 64], detailed linker histone sequence and posttranslational modification (PTM) [65] as well as catalysis of an (O-linked β-N-acetylglucosamine) O-GlcNAc PTM of nuclear and cytosolic protein [66], allosteric interaction networks and signaling pathways [67], and in higher-order organization [68]. This expectation not only can help in prediction of ligand binding [69] but also has inspired the proposition that accounting for conformational heterogeneity and dynamics would benefit protein design methods [70].…”